Israel - heprea - Ministry of Health

tec-o-pharm-libra ltd - trospium chloride - טבליות מצופות פילם - trospium chloride 15 mg - trospium - trospium - for the treatment of vegetative bladder dysfunction, urge and reflex incontinence.

Israel - heprea - Ministry of Health

unipharm ltd, israel - clarithromycin - טבליות מצופות - clarithromycin 250 mg - clarithromycin - clarithromycin - karin is indicated in the treatment of infections caused by one or more susceptible organisms. lower respiratory tract infections for example, acute and chronic bronchitis, and pneumonia. upper respiratory tract infections for example, sinusitis and pharyngitis. karin is also indicated in skin and soft tissue infections of mild to moderate severity. karin is also indicated in combination with proton pump inhibitor for the eradication of h.pylori in patients with proven duodenal ulcers.

Israel - heprea - Ministry of Health

unipharm ltd, israel - clarithromycin - טבליות מצופות - clarithromycin 500 mg - clarithromycin - clarithromycin - karin is indicated in the treatment of infections caused by one or more susceptible organisms. lower respiratory tract infections for example, acute and chronic bronchitis, and pneumonia. upper respiratory tract infections for example, sinusitis and pharyngitis. karin is also indicated in skin and soft tissue infections of mild to moderate severity.karin is also indicated in combination with proton pump inhibitor for the eradication of h.pylori in patients with proven duodenal ulcers. treatment of mycobacterium avium complex infection in aids patients

Israel - heprea - Ministry of Health

dexcel ltd, israel - clarithromycin - קפליות - clarithromycin 250 mg - clarithromycin - clarithromycin - klaridex is indicated in the treatment of infections caused by one or more susceptible organisms. indications include: lower respiratory tract infections, for example, acute and chronic bronchitis and pneumonia. upper respiratory tract infections, for example, sinusitis and pharyngitis. klaridex is appropriate for initial therapy in community acquired respiratory infections and has been shown to be active in vitro against common and atypical respiratory pathogens as listed in the microbiology section. klaridex is also indicated in skin and soft tissue infections of mild to moderate severity. klaridex is also indicated in combination with proton pump inhibitor for the eradication of h. pylori in patients with proven duodenal ulcer. treatment of mycobacterium avium complex infection in aids patients.

Israel - heprea - Ministry of Health

taro international ltd - lansoprazole 15 mg - capsules - proton pump inhibitors - for the treatment of duodenal ulcer, benign gastric ulcer, reflux oesophagitis and acid related disorders of the upper gastrointestinal tract. healing, long term treatment and maintenance therapy for patients with gastro oesophageal reflux disease (gord) or duodenal ulcer. prevention of relapse in patients with gord or duodenal ulcer. eradication of h. pylori from the upper gastrointestinal tract in patients with duodenal ulcer, gastritis or benign ulcer (in combination with appropriate antibiotics). short term treatment (up to four weeks) of heartburn and/or upper epigastric pain associated with acid-related dyspepsia. long-term management of pathological hypersecretory conditions including zollinger ellison syndrome.treatment and prophylaxis of nsaid- associated benign gastric ulcers, duodenal ulcers and relief of symptoms in patients requiring continued nsaid treatment.

Israel - heprea - Ministry of Health

taro international ltd - lansoprazole 30 mg - capsules - proton pump inhibitors - for the treatment of duodenal ulcer, benign gastric ulcer, reflux oesophagitis and acid related disorders of the upper gastrointestinal tract. healing, long term treatment and maintenance therapy for patients with gastro oesophageal reflux disease (gord) or duodenal ulcer. prevention of relapse in patients with gord or duodenal ulcer. eradication of h. pylori from the upper gastrointestinal tract in patients with duodenal ulcer, gastritis or benign ulcer (in combination with appropriate antibiotics). short term treatment (up to four weeks) of heartburn and/or upper epigastric pain associated with acid-related dyspepsia. long-term management of pathological hypersecretory conditions including zollinger ellison syndrome. treatment and prophylaxis of nsaid- associated benign gastric ulcers, duodenal ulcers and relief of symptoms in patients requiring continued nsaid treatment.

Israel - heprea - Ministry of Health

קוסמופארם בעמ - ניקוי הגוף

Israel - heprea - Ministry of Health

קוסמופארם בעמ - חפיפת שיער

Israel - heprea - Ministry of Health

בירנפלד יפה - ניקוי הפנים

Israel - heprea - Ministry of Health

לילית קוסמטיקה בעמ - לחות לעור